Datametrex AI Ltd V.DM

Alternate Symbol(s): DTMXF

Technology Software - Application

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.

TSXV:DM - Post by User

Datametrex AI Ltd

Bullboard Posts

Comment by mytriadeon Apr 19, 2020 2:48pm

175 Views

Post# 30927362

RE:RE:RE:RE:RE:RE:We will see...

I did. And what don't you get about this?
"RevealCOVID-19 is designed to detect all antibodies found in individuals who have been exposed to SARS-CoV-2 virus, the virus that causes COVID-19 disease."

so if I had covid 19 a month ago and am no longer infectious and retook the mir Test today I would come out as positive. That does not help the immediate situation of quarantining currently infected patients that are infectious.

Medmira Inc. has completed the development of the serological point-of-care (POC) testing solution.

Nucleic acid amplification testing is the diagnostic technology used by public health laboratories across Canada and around the world for diagnosing COVID-19. As such, diagnostic tests using nucleic acid technology are being prioritized for review to increase the number of tests available in Canada.

medmira submitted their application on March 24th and today they are still considered an application that is not approved. Because antibody tests have been put on the back burner.